help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dremier, S.
Right arrow Articles by Dumont, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dremier, S.
Right arrow Articles by Dumont, J. E.

Endocrinology, Vol 135, 135-140, Copyright © 1994 by Endocrine Society

ARTICLES

Mitogenic, dedifferentiating, and scattering effects of hepatocyte growth factor on dog thyroid cells

S Dremier, M Taton, K Coulonval, T Nakamura, K Matsumoto and JE Dumont
Institut de Recherche Interdisciplinaire en Biologie Humaine et Nucleaire, Faculty of Medicine, Free University of Brussels, Belgium.

Hepatocyte growth factor (HGF)/scatter factor (SF) is a potent mitogenic factor or motility factor in different cells, acting through the tyrosine kinase receptor encoded by the met protooncogene. In the present work, we demonstrate the powerful mitogenic activity of this growth factor on dog thyroid cells in primary culture. This effect, maximal at 50 ng/ml, was superior to those of other thyroid mitogenic agents, such as TSH, forskolin, and epidermal growth factor (EGF). HGF inhibited both TSH- and forskolin-stimulated iodide uptake (a thyroid- specific differentiation marker) in the same way as EGF. However, as with basic fibroblast growth factor, this dedifferentiating action appeared only during the growing phase concomitantly with the enhanced proliferation. HGF treatment also markedly decreased TSH receptor and thyroglobulin messenger RNA levels, two other markers of differentiated thyrocytes. Besides its proliferative and dedifferentiating effects, HGF enhanced the motility of the cultured thyroid cells. Concerning the mechanism of its action, we showed that HGF had no effect on basal cAMP levels, but like EGF and 12-O-tetradecanoyl-phorbol 13-acetate, it induced the rapid tyrosine phosphorylation of mitogen-activated protein kinases p42 and p44. These data establish HGF as the strongest mitogenic agent for dog thyroid cells and may explain the important role of met oncogene expression in human thyroid tumors.


This article has been cited by other articles:


Home page
 EndocrinologyHome page
S. Dremier, M. Milenkovic, S. Blancquaert, J. E. Dumont, S. O. Doskeland, C. Maenhaut, and P. P. Roger
Cyclic Adenosine 3',5'-Monophosphate (cAMP)-Dependent Protein Kinases, But Not Exchange Proteins Directly Activated by cAMP (Epac), Mediate Thyrotropin/cAMP-Dependent Regulation of Thyroid Cells
Endocrinology, October 1, 2007; 148(10): 4612 - 4622.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
N. Fortemaison, S. Blancquaert, J. E. Dumont, C. Maenhaut, K. Aktories, P. P. Roger, and S. Dremier
Differential Involvement of the Actin Cytoskeleton in Differentiation and Mitogenesis of Thyroid Cells: Inactivation of Rho Proteins Contributes to Cyclic Adenosine Monophosphate-Dependent Gene Expression but Prevents Mitogenesis
Endocrinology, December 1, 2005; 146(12): 5485 - 5495.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
T. Kimura, A. Van Keymeulen, J. Golstein, A. Fusco, J. E. Dumont, and P. P. Roger
Regulation of Thyroid Cell Proliferation by TSH and Other Factors: A Critical Evaluation of in Vitro Models
Endocr. Rev., October 1, 2001; 22(5): 631 - 656.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
W. Cai, S. L. Rook, Z. Y. Jiang, N. Takahara, and L. P. Aiello
Mechanisms of Hepatocyte Growth Factor-Induced Retinal Endothelial Cell Migration and Growth
Invest. Ophthalmol. Vis. Sci., June 1, 2000; 41(7): 1885 - 1893.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
K. Tanaka, Y. Nagayama, T. Nakano, N. Takamura, H. Namba, S. Fukada, K. Kuma, S. Yamashita, and M. Niwa
Expression Profile of Receptor-Type Protein Tyrosine Kinase Genes in the Human Thyroid
Endocrinology, March 1, 1998; 139(3): 852 - 858.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
C. U. Pietrzik, J. Hoffmann, K. Stober, C.-Y. Chen, C. Bauer, D. A. C. Otero, J.-M. Roch, and V. Herzog
From differentiation to proliferation: The secretory amyloid precursor protein as a local mediator of growth in thyroid epithelial cells
PNAS, February 17, 1998; 95(4): 1770 - 1775.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. Burikhanov, K. Coulonval, I. Pirson, F. Lamy, J. E. Dumont, and P. P. Roger
Thyrotropin via Cyclic AMP Induces Insulin Receptor Expression and Insulin Co-stimulation of Growth and Amplifies Insulin and Insulin-like Growth Factor Signaling Pathways in Dog Thyroid Epithelial Cells
J. Biol. Chem., November 15, 1996; 271(46): 29400 - 29406.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
F. Wilkin, V. Savonet, A. Radulescu, J. Petermans, J. E. Dumont, and C. Maenhaut
Identification and Characterization of Novel Genes Modulated in the Thyroid of Dogs Treated with Methimazole and Propylthiouracil
J. Biol. Chem., November 8, 1996; 271(45): 28451 - 28457.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1994 by The Endocrine Society